Blood Clot Breakdown in Severe Infection and Injury
Part of Infections, Injuries & trauma clinical trials.
This trial studies how well the body's natural clot-busting system works in people with serious infections or major injuries. It may help doctors find better ways to treat these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the ICU with a serious infection or injury.
- Doctors expect you to survive and stay in the ICU for at least two more days.
- You are not on blood-thinning medications (like warfarin or clopidogrel).
- You are receiving full, active treatment in the ICU (not just comfort care).
- If you have a trauma injury, you need breathing support and may need a blood transfusion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether using a blood test that shows clotting strength and “clot breakdown time” can help guide treatment for people in the ICU with acute respiratory failure from infection. If you qualify, the team will use these blood results to decide on clot-related therapy and compare outcomes to standard care.
This study is testing a special blood test called ROTEM to see how well it can predict bleeding problems in ICU patients with sepsis or severe trauma. It may help doctors give the right treatment faster.
This study tests a new medicine called BAY 3389934 to see if it's safe and what dose works best for people with sepsis and blood clotting issues. The goal is to improve blood clotting and help you recover from the infection.
This trial tests whether a newer, faster blood test (viscoelastic testing) can better guide treatment for bleeding after a severe injury compared to standard blood tests. If you are in the emergency room shortly after a serious trauma, this study may help doctors decide the right treatments to stop bleeding more quickly.
This study tests an investigational treatment called INTERCEPT Fibrinogen Complex (IFC) for people with severe bleeding after a traumatic injury. The treatment helps restore a key blood-clotting protein to try to stop the bleeding and improve survival.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
Hear when a new Sepsis and Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.